MedTrace Logo

Antithrombotic Therapy at the End of Life: The PEACE Study

NCT07338071 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2026-01-13

No results posted yet for this study

Summary

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

Conditions

  • Palliative Care

Interventions

DRUG

antithrombotic drugs

use of antithrombotic drug

Sponsors & Collaborators

  • Ospedale Cristo Re - Roma

    collaborator UNKNOWN

  • San Giovanni Addolorata Hospital

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2027-11-30
Completion
2027-11-30
FDA Drug
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07338071 on ClinicalTrials.gov